In line with our observations, Moriyama et al [43] established a novel xenograft model of human gastrointestinal stromal tumor (GIST) in mice, and found that c-kit expression was observed in each passage and both imatinib and sunitinib significantly reduced the size of the xenograft tumor. Here, KIT is linked to neoplasm.